Novartis Investigative Site

Vancouver, Washington 98684

0 studies enrolling now · 3 studies all time

What they study most

Leukaemia, Lymphocytic, Chronic, Lymphoma, Non-Hodgkin, Purpura, Thrombocytopaenic, Idiopathic

Studies at this site

• Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia — Stopped early
• Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) — Completed
• EXTEND (Eltrombopag Extended Dosing Study) — Completed